Dr. Martens PLCLSE: DOCS

Dr. Martens: Director/PDMR Shareholding

· Issued by Dr. Martens PLC

Summary by 6ix AI

Dr. Martens plc was notified on October 8, 2026 that Chief Executive Officer Ije Nwokorie and Chief Financial Officer Giles Wilson acquired dividend shares on October 7, 2026 under the company's Share Incentive Plan, an all-employee share scheme approved by HMRC, the UK tax authority.

Key details

  • Ije Nwokorie acquired 308 ordinary shares at £0.6780 each.
  • Giles Wilson acquired 278 ordinary shares at £0.6780 each.
  • Both transactions took place on the London Stock Exchange.
  • Under the plan, participating employees buy shares from monthly salary and receive one free matching share from the company for each share they buy.

6ix AI wrote this summary from the release below and checked it against the release.

Dr. Martens plc (the 'Company')

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

The Company announces that it was notified on 08 October 2026 of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs') under the Company's Share Incentive Plan ('SIP').

The SIP is an HMRC approved, all-employee scheme under which participating employees are able to purchase shares in the Company from monthly salary ('Partnership Shares') and receive allocations of free 'Matching Shares', awarded at a rate of one Matching Share for every one Partnership Share purchased by a participating employee, from the Company.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ije Nwokorie

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01


ISIN: GB00BL6NGV24

b)

Nature of the transaction

Acquisition of dividend shares under the SIP.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.6780

308

d)

Aggregated information

-

Aggregated volume

-

Price

n/a (single transaction)

n/a (single transaction)

e)

Date of the transaction

7 October 2026

f)

Place of the transaction

London Stock Exchange (XLON)

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Giles Wilson

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01

ISIN: GB00BL6NGV24

b)

Nature of the transaction

Acquisition of dividend shares under the SIP.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.6780

278

d)

Aggregated information

-

Aggregated volume

-

Price

n/a (single transaction)

n/a (single transaction)

e)

Date of the transaction

7 October 2026

f)

Place of the transaction

London Stock Exchange (XLON)

For further information please contact:

Rebecca Flaherty

Assistant Company Secretary

+44(0)7585 398 2165

Dr. Martens PLC on 6ix

Earlier from Dr. Martens

All Dr. Martens news releases